Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Concordance of Phosphatidylserine/Prothrombin and APhLTM Antibodies Associated With Antiphospholipid Syndrome–Associated Pregnancy Morbidity

International Society on Thrombosis and Haemostasis 31st Congress

ISTH 2023

Montreal, Canada, June 24-28, 2023

Poster presentation: Concordance of Phosphatidylserine/Prothrombin and APhLTM Antibodies Associated With Antiphospholipid Syndrome–Associated Pregnancy Morbidity

Authors: Wong ECC, Espinoza A, Worfolk LA

Specialty: Oncology, Hematology, Coagulation, Hemostasis, Womens Health, OB/GYN

Related content

Publication
Atypical presentation of pediatric antiphospholipid syndrome
Conference Presentation
Evaluation of Heparin-induced Thrombocytopenia Before and during the COVID-19 Pandemic at a US National Reference Laboratory
Test FAQ
Anti PF4 and Serotonin Release Assay SRA for Diagnosing Heparin induced Thrombocytopenia Thrombosis HIT HITT
Test FAQ
Antiphospholipid Antibodies
Test FAQ
Phosphatidylserine-Prothrombin Antibodies, IgG, IgM
Test FAQ
Prothrombin Time With INR

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.